Skip to main content
2025 Canadian Cardiovascular Congress Main banner
Session Evaluation

Prevention

Education

Advocacy

Cardio Obstetrics

Nursing & Allied Health

Canadian Council of Cardiovascular Nurses(CCCN)

Canadian Association of Interventional Cardiology (CAIC)
Session Type: Workshop

322 - UNDERSTANDING CARDIOVASCULAR HEALTH AND DISEASE IN YOUNG WOMEN: PCOS, ASSISTED REPRODUCTION, PREECLAMPSIA & PREMATURE MENOPAUSE

Saturday, October 25, 2025
11:15am - 12:15pm ET
Room:204AB

Target Audience: General: All cardiovascular (clinical and research) health professionals, Trainee (clinical), Cardiac technicians & nurses

Workshop Description: Young women are a uniquely challenging population that make many cardiologists uneasy. Traditional risk assessment tools, such as the Framingham risk score, do not capture the various risk factors that affect this population. Moreover, hormonal fluctuations throughout a woman’s life, whether they are physiologic or pathologic, play a key role in cardiovascular health and disease. In this workshop, we propose a deep dive into the interplay of hormones and heart health in young women, using the 4 P’s as examples to guide discussion. First, we will discuss Polycystic ovarian syndrome, a condition that affects 10% of premenopausal women, and that carries significant cardiometabolic disruption. Tips and tricks to evaluate cardiovascular risk in young women will be discussed. Then, we will tackle the hot topic of assisted reProductive technologies, and their impact on cardiovascular health, focusing on potential complications such as ovarian hyperstimulation syndrome and multiparity, and their impact on heart health. Third, we will explore the mechanisms underlying Preeclampsia-related adverse events and discuss optimal risk reduction interventions. Lastly, we will discuss the unique challenges of accelerated vascular aging and other adverse effects of Premature and early menopause.

To achieve these ambitious objectives, we have recruited a multi-disciplinary team of experts to guide our discussions. One of the strengths of our workshop is the breadth of expertise of our committee members and speakers, which encompass various disciplines, levels of training, and geographic representation across the country, allowing us to provide robust content for this important session.

We expect that this workshop will be of great interest to the general cardiologist as well as subspecialists and will provide a platform for expert discussion on the care of this unique population.

Learning Objectives:

At the end of this session participants will be able to:
  • identify the interplay of polycystic ovarian syndrome (PCOS) and cardiovascular disease, and develop an approach to cardiovascular risk assessment in young women;
  • recognize the potential cardiovascular effects of assisted reproductive technologies and the impact of parity on heart health;
  • untangle the pathophysiological implications of preeclampsia and its associated short, medium and long-term risk for cardiac disease;
  • understand Incident atrial fibrillation following hypertensive disorders of pregnancy; and
  • understand the cardiovascular impact of early, premature, and medical/surgical menopause in young women, and review the risk assessment process for menopausal hormone therapy.